The United States Food and Drug Administration (FDA) has published new proposed guidance to the industry on assessing the safety of type 2 diabetes newer medications and withdrawn the 12-year “outdated” conditions for standardized cardiovascular outcome trials (CVOT).
The cardiovascular system showed strong circadian rhythms to retained normal functioning.
Comparison of Prognostic Significance between Serum Fibrinogen and Global Registry of Acute Coronary Events Score for Prognosis of Patients with Non-ST-elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Non-ST-elevation acute coronary syndrome (NSTE-ACS) assigns to a range of acute conditions resisting acute myocardial ischemia and infarctions that are common because of a sudden decrease in myocardial coronary blood flow.
Risk Factors, Incidence, and Outcomes of Cardiac Arrhythmia among Autologous Stem Cell Transplant Recipients
The occurrence of arrhythmias has been reported to be as high as 9-27% in an autologous or allogeneic transplant.
Most of the sodium we eat more than 70% comes from packaged and restaurant foods.
Statin Therapy is associated with Better Ambulatory Blood Pressure Control: A Propensity Score Analysis
Hypercholesterolemia and hypertension normally coexist, serving as the prime alterable cardiovascular risk factors.